Herbas VPB

Print
EN | LT
LT - Radioaktyviai žymėti 2-amino-6-fluor-N-[5-fluor-piridin-il]- pirazolo[1,5-a]pirimidin-3-karboksamido junginio dariniai, naudingi kaip ATR kinazės inhibitoriai, minėto junginio gamybos būdas ir jo skirtingos kietos formos
EN - RADIOLABELLED DERIVATIVES OF A 2-AMINO-6-FLUORO-N-[5-FLUORO-PYRIDIN-3-YL]- PYRAZOLO[1,5-A]PYRIMIDIN-3-CARBOXAMIDE COMPOUND USEFUL AS ATR KINASE INHIBITOR, THE PREPARATION OF SAID COMPOUND AND DIFFERENT SOLID FORMS THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 487/04 (2006.01)
European patent
(11) Number of the document 3152212
(13) Kind of document T
(96) European patent application number 15745265.7
Date of filing the European patent application 2015-05-28
(97) Date of publication of the European application 2017-04-12
(45) Date of publication and mention of the grant of the patent 2019-12-11
(46) Date of publication of the claims translation 2020-05-11
PCT application
(86) Number PCT/US2015/032879
Date 2015-05-28
PCT application publication
(87) Number WO 2015/187451
Date 2015-12-10
Priority applications
(30) Number Date Country code
201462008277 P 2014-06-05 US
Inventors
(72)
AHMAD, Nadia, GB
CHARRIER, Jean-Damien, GB
DAVIS, Chris, GB
ETXEBARRIA I JARDI, Gorka, GB
FRAYSSE, Damien, GB
KNEGTEL, Ronald, GB
PANESAR, Maninder, GB
PIERARD, Francoise, GB
PINDER, Joanne, GB
STORCK, Pierre-Henri, GB
STUDLEY, John, GB
Grantee
(73) Vertex Pharmaceuticals Inc., 50 Northern Avenue 15th Floor, Boston, MA 02210, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Radioaktyviai žymėti 2-amino-6-fluor-N-[5-fluor-piridin-il]- pirazolo[1,5-a]pirimidin-3-karboksamido junginio dariniai, naudingi kaip ATR kinazės inhibitoriai, minėto junginio gamybos būdas ir jo skirtingos kietos formos
  RADIOLABELLED DERIVATIVES OF A 2-AMINO-6-FLUORO-N-[5-FLUORO-PYRIDIN-3-YL]- PYRAZOLO[1,5-A]PYRIMIDIN-3-CARBOXAMIDE COMPOUND USEFUL AS ATR KINASE INHIBITOR, THE PREPARATION OF SAID COMPOUND AND DIFFERENT SOLID FORMS THEREOF
Last renewal fee
Payment date Validity (years) Amount
2025-05-05 11 289.00 EUR
Next renewal fee
2026-05-28